nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—respiratory system—chronic obstructive pulmonary disease	0.0492	0.163	CbGeAlD
Miglustat—UGCG—respiratory system—chronic obstructive pulmonary disease	0.0485	0.16	CbGeAlD
Miglustat—GBA2—bronchus—chronic obstructive pulmonary disease	0.0405	0.134	CbGeAlD
Miglustat—UGCG—bronchus—chronic obstructive pulmonary disease	0.0399	0.132	CbGeAlD
Miglustat—GBA2—trachea—chronic obstructive pulmonary disease	0.0363	0.12	CbGeAlD
Miglustat—UGCG—trachea—chronic obstructive pulmonary disease	0.0358	0.119	CbGeAlD
Miglustat—GBA2—lung—chronic obstructive pulmonary disease	0.0261	0.0864	CbGeAlD
Miglustat—UGCG—lung—chronic obstructive pulmonary disease	0.0257	0.0852	CbGeAlD
Miglustat—Neuropathy—Montelukast—chronic obstructive pulmonary disease	0.0054	0.00774	CcSEcCtD
Miglustat—Cramps of lower extremities—Formoterol—chronic obstructive pulmonary disease	0.0054	0.00773	CcSEcCtD
Miglustat—Cramps of lower extremities—Arformoterol—chronic obstructive pulmonary disease	0.0054	0.00773	CcSEcCtD
Miglustat—Cognitive disorder—Prednisone—chronic obstructive pulmonary disease	0.00535	0.00766	CcSEcCtD
Miglustat—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00528	0.00757	CcSEcCtD
Miglustat—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.00512	0.00733	CcSEcCtD
Miglustat—Cramps of lower extremities—Salbutamol—chronic obstructive pulmonary disease	0.0051	0.0073	CcSEcCtD
Miglustat—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00509	0.00729	CcSEcCtD
Miglustat—Malnutrition—Roflumilast—chronic obstructive pulmonary disease	0.00506	0.00725	CcSEcCtD
Miglustat—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00491	0.00704	CcSEcCtD
Miglustat—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00489	0.00701	CcSEcCtD
Miglustat—Muscle spasms—Roflumilast—chronic obstructive pulmonary disease	0.00486	0.00697	CcSEcCtD
Miglustat—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00474	0.00679	CcSEcCtD
Miglustat—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00469	0.00673	CcSEcCtD
Miglustat—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00456	0.00654	CcSEcCtD
Miglustat—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.00455	0.00651	CcSEcCtD
Miglustat—Neuritis—Prednisolone—chronic obstructive pulmonary disease	0.00426	0.0061	CcSEcCtD
Miglustat—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00426	0.0061	CcSEcCtD
Miglustat—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.00418	0.00598	CcSEcCtD
Miglustat—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00405	0.0058	CcSEcCtD
Miglustat—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.00396	0.00568	CcSEcCtD
Miglustat—Cramp muscle—Arformoterol—chronic obstructive pulmonary disease	0.00384	0.0055	CcSEcCtD
Miglustat—Cramp muscle—Formoterol—chronic obstructive pulmonary disease	0.00384	0.0055	CcSEcCtD
Miglustat—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00379	0.00542	CcSEcCtD
Miglustat—Cramp muscle—Montelukast—chronic obstructive pulmonary disease	0.00376	0.00539	CcSEcCtD
Miglustat—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00373	0.00535	CcSEcCtD
Miglustat—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00368	0.00527	CcSEcCtD
Miglustat—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00364	0.00521	CcSEcCtD
Miglustat—Cramp muscle—Salbutamol—chronic obstructive pulmonary disease	0.00363	0.00519	CcSEcCtD
Miglustat—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00359	0.00515	CcSEcCtD
Miglustat—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00359	0.00514	CcSEcCtD
Miglustat—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00357	0.00511	CcSEcCtD
Miglustat—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00356	0.0051	CcSEcCtD
Miglustat—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00353	0.00506	CcSEcCtD
Miglustat—Visual impairment—Tiotropium—chronic obstructive pulmonary disease	0.00352	0.00505	CcSEcCtD
Miglustat—Abdominal distension—Salbutamol—chronic obstructive pulmonary disease	0.0035	0.00502	CcSEcCtD
Miglustat—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00342	0.00489	CcSEcCtD
Miglustat—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.0034	0.00487	CcSEcCtD
Miglustat—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00338	0.00484	CcSEcCtD
Miglustat—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00328	0.00469	CcSEcCtD
Miglustat—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00326	0.00468	CcSEcCtD
Miglustat—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.0032	0.00459	CcSEcCtD
Miglustat—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00318	0.00456	CcSEcCtD
Miglustat—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00316	0.00453	CcSEcCtD
Miglustat—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.00316	0.00452	CcSEcCtD
Miglustat—Neuritis—Prednisone—chronic obstructive pulmonary disease	0.0031	0.00444	CcSEcCtD
Miglustat—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00308	0.00441	CcSEcCtD
Miglustat—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.00304	0.00436	CcSEcCtD
Miglustat—Neuropathy—Prednisolone—chronic obstructive pulmonary disease	0.00299	0.00428	CcSEcCtD
Miglustat—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00296	0.00424	CcSEcCtD
Miglustat—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.00295	0.00422	CcSEcCtD
Miglustat—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00292	0.00419	CcSEcCtD
Miglustat—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.0029	0.00415	CcSEcCtD
Miglustat—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.0029	0.00415	CcSEcCtD
Miglustat—Hypoaesthesia—Montelukast—chronic obstructive pulmonary disease	0.00287	0.00412	CcSEcCtD
Miglustat—Visual impairment—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00407	CcSEcCtD
Miglustat—Visual impairment—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00407	CcSEcCtD
Miglustat—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00284	0.00407	CcSEcCtD
Miglustat—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00283	0.00405	CcSEcCtD
Miglustat—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.0028	0.00401	CcSEcCtD
Miglustat—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00279	0.00399	CcSEcCtD
Miglustat—Hypoaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00397	CcSEcCtD
Miglustat—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.00392	CcSEcCtD
Miglustat—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00273	0.00391	CcSEcCtD
Miglustat—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.00387	CcSEcCtD
Miglustat—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00265	0.0038	CcSEcCtD
Miglustat—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00263	0.00376	CcSEcCtD
Miglustat—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00262	0.00376	CcSEcCtD
Miglustat—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00259	0.00371	CcSEcCtD
Miglustat—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00258	0.0037	CcSEcCtD
Miglustat—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00258	0.0037	CcSEcCtD
Miglustat—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00257	0.00368	CcSEcCtD
Miglustat—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00257	0.00368	CcSEcCtD
Miglustat—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00255	0.00365	CcSEcCtD
Miglustat—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00253	0.00363	CcSEcCtD
Miglustat—Chills—Salbutamol—chronic obstructive pulmonary disease	0.0025	0.00358	CcSEcCtD
Miglustat—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00249	0.00357	CcSEcCtD
Miglustat—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00249	0.00357	CcSEcCtD
Miglustat—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00249	0.00357	CcSEcCtD
Miglustat—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00356	CcSEcCtD
Miglustat—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00356	CcSEcCtD
Miglustat—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00247	0.00354	CcSEcCtD
Miglustat—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.00354	CcSEcCtD
Miglustat—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00245	0.00351	CcSEcCtD
Miglustat—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.0035	CcSEcCtD
Miglustat—Visual disturbance—Prednisolone—chronic obstructive pulmonary disease	0.00244	0.00349	CcSEcCtD
Miglustat—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00347	CcSEcCtD
Miglustat—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00242	0.00347	CcSEcCtD
Miglustat—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00242	0.00346	CcSEcCtD
Miglustat—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00241	0.00345	CcSEcCtD
Miglustat—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00241	0.00345	CcSEcCtD
Miglustat—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00239	0.00343	CcSEcCtD
Miglustat—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.00239	0.00342	CcSEcCtD
Miglustat—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00341	CcSEcCtD
Miglustat—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00341	CcSEcCtD
Miglustat—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00236	0.00338	CcSEcCtD
Miglustat—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.00337	CcSEcCtD
Miglustat—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00235	0.00336	CcSEcCtD
Miglustat—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00336	CcSEcCtD
Miglustat—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00233	0.00334	CcSEcCtD
Miglustat—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00334	CcSEcCtD
Miglustat—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00232	0.00332	CcSEcCtD
Miglustat—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00232	0.00332	CcSEcCtD
Miglustat—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00229	0.00327	CcSEcCtD
Miglustat—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00227	0.00325	CcSEcCtD
Miglustat—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00225	0.00323	CcSEcCtD
Miglustat—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00322	CcSEcCtD
Miglustat—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00224	0.00321	CcSEcCtD
Miglustat—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00222	0.00318	CcSEcCtD
Miglustat—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00219	0.00313	CcSEcCtD
Miglustat—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00218	0.00312	CcSEcCtD
Miglustat—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00218	0.00312	CcSEcCtD
Miglustat—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00218	0.00312	CcSEcCtD
Miglustat—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00217	0.00311	CcSEcCtD
Miglustat—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00216	0.00309	CcSEcCtD
Miglustat—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00216	0.00309	CcSEcCtD
Miglustat—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00306	CcSEcCtD
Miglustat—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00306	CcSEcCtD
Miglustat—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00304	CcSEcCtD
Miglustat—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00206	0.00294	CcSEcCtD
Miglustat—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00206	0.00294	CcSEcCtD
Miglustat—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00205	0.00294	CcSEcCtD
Miglustat—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00204	0.00292	CcSEcCtD
Miglustat—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00204	0.00292	CcSEcCtD
Miglustat—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00289	CcSEcCtD
Miglustat—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00288	CcSEcCtD
Miglustat—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00288	CcSEcCtD
Miglustat—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.00201	0.00288	CcSEcCtD
Miglustat—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00278	CcSEcCtD
Miglustat—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.0019	0.00272	CcSEcCtD
Miglustat—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.0019	0.00272	CcSEcCtD
Miglustat—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00189	0.0027	CcSEcCtD
Miglustat—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00188	0.0027	CcSEcCtD
Miglustat—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00186	0.00266	CcSEcCtD
Miglustat—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00184	0.00264	CcSEcCtD
Miglustat—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00184	0.00264	CcSEcCtD
Miglustat—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00184	0.00264	CcSEcCtD
Miglustat—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00182	0.00261	CcSEcCtD
Miglustat—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00259	CcSEcCtD
Miglustat—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00259	CcSEcCtD
Miglustat—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00181	0.00259	CcSEcCtD
Miglustat—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00259	CcSEcCtD
Miglustat—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00259	CcSEcCtD
Miglustat—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00257	CcSEcCtD
Miglustat—Pain—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00257	CcSEcCtD
Miglustat—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00179	0.00257	CcSEcCtD
Miglustat—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00179	0.00257	CcSEcCtD
Miglustat—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00256	CcSEcCtD
Miglustat—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.00179	0.00256	CcSEcCtD
Miglustat—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00255	CcSEcCtD
Miglustat—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00254	CcSEcCtD
Miglustat—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00254	CcSEcCtD
Miglustat—Pain—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00251	CcSEcCtD
Miglustat—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00175	0.00251	CcSEcCtD
Miglustat—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00174	0.0025	CcSEcCtD
Miglustat—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00174	0.0025	CcSEcCtD
Miglustat—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00173	0.00247	CcSEcCtD
Miglustat—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00173	0.00247	CcSEcCtD
Miglustat—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00173	0.00247	CcSEcCtD
Miglustat—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00246	CcSEcCtD
Miglustat—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00172	0.00246	CcSEcCtD
Miglustat—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00246	CcSEcCtD
Miglustat—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00246	CcSEcCtD
Miglustat—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00245	CcSEcCtD
Miglustat—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00244	CcSEcCtD
Miglustat—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00242	CcSEcCtD
Miglustat—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00169	0.00242	CcSEcCtD
Miglustat—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00168	0.0024	CcSEcCtD
Miglustat—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00237	CcSEcCtD
Miglustat—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00237	CcSEcCtD
Miglustat—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00165	0.00237	CcSEcCtD
Miglustat—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00164	0.00234	CcSEcCtD
Miglustat—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00163	0.00234	CcSEcCtD
Miglustat—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00163	0.00233	CcSEcCtD
Miglustat—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00162	0.00232	CcSEcCtD
Miglustat—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00232	CcSEcCtD
Miglustat—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00161	0.0023	CcSEcCtD
Miglustat—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.0016	0.00229	CcSEcCtD
Miglustat—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00224	CcSEcCtD
Miglustat—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.00221	CcSEcCtD
Miglustat—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.00154	0.00221	CcSEcCtD
Miglustat—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00215	CcSEcCtD
Miglustat—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00215	CcSEcCtD
Miglustat—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00148	0.00212	CcSEcCtD
Miglustat—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00211	CcSEcCtD
Miglustat—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.00146	0.00209	CcSEcCtD
Miglustat—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00205	CcSEcCtD
Miglustat—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00205	CcSEcCtD
Miglustat—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00203	CcSEcCtD
Miglustat—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.0014	0.00201	CcSEcCtD
Miglustat—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00199	CcSEcCtD
Miglustat—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00199	CcSEcCtD
Miglustat—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00194	CcSEcCtD
Miglustat—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00194	CcSEcCtD
Miglustat—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00191	CcSEcCtD
Miglustat—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00191	CcSEcCtD
Miglustat—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00188	CcSEcCtD
Miglustat—Headache—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00188	CcSEcCtD
Miglustat—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00131	0.00188	CcSEcCtD
Miglustat—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00187	CcSEcCtD
Miglustat—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00187	CcSEcCtD
Miglustat—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.00185	CcSEcCtD
Miglustat—Depression—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00185	CcSEcCtD
Miglustat—Headache—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00184	CcSEcCtD
Miglustat—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00127	0.00182	CcSEcCtD
Miglustat—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.0018	CcSEcCtD
Miglustat—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.0018	CcSEcCtD
Miglustat—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00179	CcSEcCtD
Miglustat—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00178	CcSEcCtD
Miglustat—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00178	CcSEcCtD
Miglustat—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00178	CcSEcCtD
Miglustat—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00122	0.00175	CcSEcCtD
Miglustat—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00121	0.00173	CcSEcCtD
Miglustat—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00168	CcSEcCtD
Miglustat—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00168	CcSEcCtD
Miglustat—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00167	CcSEcCtD
Miglustat—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00166	CcSEcCtD
Miglustat—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00163	CcSEcCtD
Miglustat—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00108	0.00155	CcSEcCtD
Miglustat—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00147	CcSEcCtD
Miglustat—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00146	CcSEcCtD
Miglustat—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00146	CcSEcCtD
Miglustat—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00145	CcSEcCtD
Miglustat—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000971	0.00139	CcSEcCtD
Miglustat—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000938	0.00134	CcSEcCtD
Miglustat—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000935	0.00134	CcSEcCtD
Miglustat—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000911	0.00131	CcSEcCtD
Miglustat—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000908	0.0013	CcSEcCtD
Miglustat—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000876	0.00125	CcSEcCtD
Miglustat—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.00085	0.00122	CcSEcCtD
Miglustat—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000809	0.00116	CcSEcCtD
Miglustat—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000786	0.00113	CcSEcCtD
Miglustat—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000751	0.00108	CcSEcCtD
Miglustat—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000746	0.00107	CcSEcCtD
Miglustat—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000741	0.00106	CcSEcCtD
Miglustat—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000726	0.00104	CcSEcCtD
Miglustat—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000717	0.00103	CcSEcCtD
Miglustat—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000711	0.00102	CcSEcCtD
Miglustat—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000711	0.00102	CcSEcCtD
Miglustat—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000705	0.00101	CcSEcCtD
Miglustat—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.00068	0.000974	CcSEcCtD
Miglustat—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000674	0.000966	CcSEcCtD
Miglustat—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000674	0.000966	CcSEcCtD
Miglustat—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000652	0.000934	CcSEcCtD
Miglustat—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000592	0.000848	CcSEcCtD
Miglustat—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000564	0.000808	CcSEcCtD
Miglustat—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000545	0.000781	CcSEcCtD
Miglustat—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000524	0.000751	CcSEcCtD
Miglustat—Headache—Prednisone—chronic obstructive pulmonary disease	0.000517	0.00074	CcSEcCtD
Miglustat—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00049	0.000702	CcSEcCtD
